Corpus Intelligence IC Memo — SOLDIERS & SAILORS MEMORIAL HOSPITAL 2026-04-26 19:00 UTC
IC Memo — SOLDIERS & SAILORS MEMORIAL HOSPITAL
Investment Committee Memorandum | NY | 25 beds | Grade C | EBITDA uplift $2.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SOLDIERS & SAILORS MEMORIAL HOSPITAL

CCN 331314 | YATES, NY | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SOLDIERS & SAILORS MEMORIAL HOSPITAL is a 25-bed under-performing / distressed in YATES, NY with $37.9M in net patient revenue and a -14.7% operating margin. The hospital serves a payer mix of 32.8% Medicare, 1.3% Medicaid, and 65.8% commercial.

Thesis: Turnaround. Our ML models identify $2.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.7% to -7.3% (+736bps).

Net Revenue HCRIS$37.9M
Current EBITDA COMPUTED$-5.6M
Operating Margin COMPUTED-14.7%
Occupancy HCRIS31.3%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS43.6%
Distress Probability ML52.8%

2. Market Context & Competitive Position

196
NY Hospitals
-17.5%
State Median Margin
30
Comparable Hospitals

NY has 196 Medicare-certified hospitals with a median operating margin of -17.5%. The target's margin of -14.7% places it above the state median. Among 30 size-comparable peers (12-50 beds), the median margin is -17.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 30 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SOLDIERS & SAILORS MEMORIAL HO (Target)NY25$37.9M-14.7%
NEW YORK EYE AND EAR INFIRMARYNY15$112.8M-28.0%
CLAXTON HEPBURN MEDICAL CENTERNY38$106.9M-16.0%
ALICE HYDE MEDICAL CENTERNY40$79.7M-29.4%
LEWIS COUNTY GENERAL HOSPITALNY25$70.3M-17.6%
JONES MEMORIAL HOSPITALNY49$60.7M-22.3%
CARTHAGE AREA HOSPITALNY25$59.4M-12.3%
WYOMING COUNTY COMMUNITY HOSPINY47$58.1M-42.1%
SUNNYVIEW HOSPITAL AND REHABILNY17$56.6M-9.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$796K+210bp18mo
Cost to Collect4.5%2.5%$759K+200bp12mo
Denial Rate Reduction12.0%6.5%$751K+198bp12mo
A/R Days Reduction5200.0%3800.0%$462K+122bp9mo
Clean Claim Rate88.0%96.0%$24K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$796K
Cost to Collect
$759K
Denial Rate Reduction
$751K
A/R Days Reduction
$462K
Clean Claim Rate
$24K
Total EBITDA Uplift$2.8M
Current EBITDA$-5.6M
+ RCM Uplift+$2.8M
Pro Forma EBITDA$-2.8M
Current Margin-14.7%
Pro Forma Margin-7.3%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-8.6M$-8.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-8.6M$-12.4M0.00x-100.0%
Bull Case9.0x11.0x$-7.7M$-6.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-7.7M$-8.8M0.00x-100.0%
Bear Case11.0x10.0x$-9.4M$-20.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-9.4M$-25.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 31.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 52.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 30 hospitals with 12-50 beds
  • Same-state prioritization (n=31)
  • Comp margins: P25=-28.0% / P50=-17.8% / P75=-9.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.